Center for Retina & Macular Disease

Winter Haven, Florida 33880

0 studies enrolling now · 9 studies all time

What they study most

Age Related Macular Degeneration, Choroidal Neovascularization, Diabetic Macular Edema, Exudative Age-related Macular Degeneration, Geographic Atrophy of the Macula, Macular Degeneration, Macular Edema, Non-proliferative Diabetic Retinopathy, Pigment Epithelial Detachment, Retinal Vein Occlusion, Symptomatic Vitreomacular Adhesion, Wet Age Related Macular Degeneration

Studies at this site

• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) — Stopped early
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD — Completed
• Ocriplasmin Research to Better Inform Treatment (ORBIT) — Completed
• Sensitivity of the Home Macular Perimeter (HMP) — Completed
• iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) — Stopped early